Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials - Jedynak, Jakub; Eross, Eric; Gendolla, Astrid; Rettiganti, Mallikarjuna; Stauffer, Virginia L. (Journal of headache and pain, 2021)
Keywords: Antibodies, Monoclonal, Humanized; Clinical trials; Dosage; Drug therapy; Episodic migraine; Headache; Headaches; Humans; Internal Medicine; Medicine; Medicine & Public Health; MIDAS; Migraine; Migraine Disorders - drug therapy; Migraine frequency; Monoclonal antibodies; MSQ-RFR; Neurology; Pain Medicine; Patients; Placebos; QoL; Quality of Life; Randomized Controlled Trials as Topic; Remission; Research Article; Sustained improvement; Migraine frequency; MSQ-RFR; Sustained improvement; Episodic migraine; MIDAS; QoL